Protic D, Stojkovic M, Budimirovic D. TARGETED DRUG DEVELOPMENT IN FRAGILE X SYNDROME: MOLECULAR MEDICINE AS A KEY TOOL IN CLINICAL PHARMACOLOGY. medi [Internet]. 2025 Sep. 26 [cited 2026 Jul. 12];59(2). Available from: https://asistent.ceon.rs/index.php/medi/article/view/60213